Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer

Cancer

Volumn 119, Issue 18, 2013, Pages 3402-3410

  Chang, Joe Y ^a   Liu, Yung Hsien ^a   Zhu, Zhengfei ^a   Welsh, James W ^a   Gomez, Daniel R ^a   Komaki, Ritsuko ^a   Roth, Jack A ^a   Swisher, Stephen G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

metachronous tumors; multiple primary lung cancer; stereotactic ablative radiotherapy; stereotactic body radiotherapy; synchronous tumors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIPLE PRIMARY LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION PNEUMONIA; RIB FRACTURE; SKIN TOXICITY; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; THORAX PAIN; TREATMENT OUTCOME;

METACHRONOUS TUMORS; MULTIPLE PRIMARY LUNG CANCER; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; SYNCHRONOUS TUMORS;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RADIATION DOSAGE; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84883599546     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28217     Document Type: Article

References (31)

1. Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007; 133: 1193-1200. (Pubitemid 46635515)
2. Aziz TM, Saad RA, Glasser J, et al. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002; 21: 527-533. (Pubitemid 34224813)
3. Rosengart TK, Martini N, Ghosn P, et al. Multiple primary lung carcinomas: prognosis and treatment. Ann Thorac Surg. 1991; 52: 773-778.
4. Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I non-small-cell lung cancer. Ann Thorac Surg. 2003; 76: 1001-1007.
5. Bhaskarla A, Tang PC, Mashtare T, et al. Analysis of second primary lung cancers in the SEER database. J Surg Res. 2010; 162: 1-6.
6. Shen KR, Meyers BF, Larner JM, et al. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132: 290S-305S. (Pubitemid 47502814)
7. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303: 1070-1076.
8. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009; 27: 3290-3296.
9. Chang JY, Liu H, Balter P, et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer [serial online]. Radiat Oncol. 2012; 7: 152.
10. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer. 2004; 101: 1623-1631. (Pubitemid 39318910)
11. Creach KM, Bradley JD, Mahasittiwat P, et al. Stereotactic body radiation therapy in the treatment of multiple primary lung cancers. Radiother Oncol. 2012; 104: 19-22.
12. Matthiesen C, Thompson JS, De La Fuente Herman T, et al. Use of stereotactic body radiation therapy for medically inoperable multiple primary lung cancer. J Med Imaging Radiat Oncol. 2012; 56: 561-566.
13. Sinha B, McGarry RC,. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys. 2006; 66: 1120-1124. (Pubitemid 44633514)
14. Martini N, Melamed M,. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975; 70: 606-612.
15. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008; 72: 967-971.
16. Kelly P, Balter PA, Rebueno N, et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys. 2010; 78: 1387-1393.
17. Liu H, Zhang X, Vinogradskiy YY, et al. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012; 84: 1017-1023.
18. Chang JY, Komaki R, Lu C, et al Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer. 2011; 117: 4707-4713.
19. Zhang X, Liu H, Balter P, et al. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012; 85: 1558-1565.
20. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2: 706-714. (Pubitemid 47357522)
21. Watanabe Y, Shimizu J, Oda M, et al. Second surgical intervention for recurrent and second primary bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg. 1992; 26: 73-78.
22. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011; 81: 1352-1358.
23. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I nonsmall-cell lung cancer. J Clin Oncol. 2010; 28: 928-935.
24. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg. 2010; 140: 377-386.
25. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012; 84: 1060-1070.
26. Ferguson MK,. Synchronous primary lung cancers. Chest. 1993; 103: 398S-400S. (Pubitemid 23110363)
27. Deschamps C, Pairolero PC, Trastek VF, et al. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990; 99: 769-777.
28. van Bodegom PC, Wagenaar SS, Corrin B, et al. Second primary lung cancer: importance of long term follow up. Thorax. 1989; 44: 788-793. (Pubitemid 19255908)
29. Bongers EM, Haasbeek CJ, Lagerwaard FJ, et al. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early stage lung cancer. J Thorac Oncol. 2011; 6: 2052-2057.
30. Welsh J, Thomas J, Shah D, et al. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2011; 81: 91-96.
31. Creach KM, El Naqa I, Bradley JD, et al. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. Radiother Oncol. 2012; 104: 23-27.